B&K Corporation Limited

HK$3.10As of Sun 8 Nov 2026, 12:00 UTC
HKEX:2396Healthcare
Country Hong Kong
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE —
Biotechnology
Beta (5Y) —
PE TTM —
TSR TTM —
Mkt cap HK$364.2M
ROIC —
SE Grade™
Value
Quality
Moat
Consensus
Reference
$3.45
11.56%
(79.53%)
Hold 8|0|8|9|1
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.05
0.05
0.05
0.05
20.88%
17.74%
6.91%
5.44%
Revenue¥M
24.58
24.40
24.44
25.89
(0.34%)
(0.85%)
1.26%
3.38%
Peers (US$46.30M)
Cap (US$)
PE
140.4M
6.941x
134.3M
—
46.32M
—
Capital
TTM
5Y
10Y
Leveragex
0.762
0.068
0.064
EBIT/Intx
4.478
0.066
0.062
Own earn%
25.37
(49.05)
(55.08)
Sh yield%
20.49
21.49
25.13
Owners
Insiders/Inst%
2.68
74.39
Short interest%
3.73
SBC / revenue%
3.32
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
17
Op margin range%
0–5
$1 testx
—
Incr. ROIC%
4